Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Aligos Therapeutics
ALGS
$29.3M
| $240K | ﹤0.01% |
12,854
-4,368
| -25% | -$96.8K |
|
3027
Celcuity
CELC
$4.53B
| $239K | ﹤0.01% |
26,156
-4,900
| -16% | -$48.2K |
|
3028
Genworth Financial
GNW
$3.71B
| $239K | ﹤0.01% |
+40,800
| New | +$236K |
|
|
CLSD
3029
DELISTED
Clearside Biomedical
CLSD
| $238K | ﹤0.01% |
18,219
-4,227
| -19% | -$64K |
|
3030
Astrana Health
ASTH
$1.78B
| $238K | ﹤0.01% |
+7,700
| New | +$266K |
|
3031
Academy Sports + Outdoors
ASO
$2.97B
| $236K | ﹤0.01% |
5,000
-230,200
| -98% | -$12.3M |
|
3032
Cocrystal Pharma
COCP
$14.1M
| $236K | ﹤0.01% |
126,228
+1,700
| +1% | +$4.27K |
|
3033
Comstock
LODE
$235M
| $236K | ﹤0.01% |
57,610
+3,789
| +7% | +$19.7K |
|
3034
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $235K | ﹤0.01% |
+4,600
| New | +$251K |
|
|
SWKH
3035
DELISTED
SWK Holdings
SWKH
| $235K | ﹤0.01% |
18,804
+1,893
| +11% | +$24K |
|
3036
CI&T Inc
CINT
$458M
| $234K | ﹤0.01% |
+35,959
| New | +$211K |
|
3037
Fulcrum Therapeutics
FULC
$288M
| $234K | ﹤0.01% |
52,734
-292,076
| -85% | -$1.28M |
|
|
GDEN
3038
DELISTED
Golden Entertainment
GDEN
| $234K | ﹤0.01% |
6,850
-10,446
| -60% | -$401K |
|
3039
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
| $234K | ﹤0.01% |
1,200
-3,700
| -76% | -$755K |
|
3040
Similarweb
SMWB
$652M
| $233K | ﹤0.01% |
35,900
+300
| +0.8% | +$1.96K |
|
3041
Fate Therapeutics
FATE
$303M
| $232K | ﹤0.01% |
109,219
-563,097
| -84% | -$1.87M |
|
3042
ReNew
RNW
$2.23B
| $232K | ﹤0.01% |
42,800
-35,700
| -45% | -$211K |
|
3043
Jerash Holdings
JRSH
$61M
| $231K | ﹤0.01% |
76,240
-7,808
| -9% | -$27.2K |
|
3044
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$765M
| $230K | ﹤0.01% |
+4,000
| New | +$240K |
|
3045
Legacy Housing
LEGH
$654M
| $227K | ﹤0.01% |
11,700
+2,000
| +21% | +$44K |
|
3046
Pulmatrix
PULM
$6.03M
| $226K | ﹤0.01% |
111,265
+2,253
| +2% | +$5.56K |
|
3047
Schwab US Large-Cap Growth ETF
SCHG
$62.2B
| $225K | ﹤0.01% |
12,400
-51,200
| -81% | -$964K |
|
3048
Cytosorbents Corp
CTSO
$24.2M
| $224K | ﹤0.01% |
119,100
+200
| +0.2% | +$574 |
|
3049
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.38B
| $224K | ﹤0.01% |
2,000
-200
| -9% | -$23.9K |
|
|
SFT
3050
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $224K | ﹤0.01% |
140,172
-58,800
| -30% | -$94.7K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.